DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx by Asmae El Maangar (19690522)

“…We show that using hydrotropes as a diluent decreases the viscosity of solutions by more than a factor of ten, even under high load by extracted cations. …”

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Non-linear load’s individual harmonic currents as a percentage of the fundamental value for TS3. by Abdallah Aldosary (21370131)

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Linear regression analysis. by Young Kyu Lee (14076058)

“…</p><p> Conclusion </p><p>The HTRT group showed a greater decrease in HU both pre- and post-treatment, indicating a possible indirect marker of tumor necrosis. …”

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

The motor torque curves of load increase/decrease (A) the load of 10 N • m (B) the load of 20 N • m. by Taochang Li (20642935)

“…<p>The motor torque curves of load increase/decrease (A) the load of 10 N • m (B) the load of 20 N • m.…”

The motor speed curves of load increase/decrease (A) the load of 10 N • m (B) the load of 20 N • m. by Taochang Li (20642935)

“…<p>The motor speed curves of load increase/decrease (A) the load of 10 N • m (B) the load of 20 N • m.…”

Table_2_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX by Sara Gonia (14132166)

“…Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”

Table_1_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX by Sara Gonia (14132166)

“…Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

Loading mode. by Maogang Tian (21485116)

“…Furthermore, parametric studies reveal that the pile base displacement exhibits a non-linear trend of initially decreasing and then increasing with larger inclination angles of the inclined piles. …”

Processing of wakefulness and sleep EEG data to calculate the HFD in a representative subject. by Francesco Colussi (22421582)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Raw data for "Wing and pappus appendages decrease seed terminal velocity: A meta-analysis" by Sle-gee Lee (22511645)

Relationship between the Gender Representation Disparity Index (GRDI) and average explicit sex markers in film criticism, illustrating a decrease in markers as the GRDI moves toward a female-dominated cast. by Jad Doughman (20636304)

“…<p>Relationship between the Gender Representation Disparity Index (GRDI) and average explicit sex markers in film criticism, illustrating a decrease in markers as the GRDI moves toward a female-dominated cast.…”

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects:

Design of a Magnetic Nanoplatform Based on CD26 Targeting and HSP90 Inhibition for Apoptosis and Ferroptosis-Mediated Elimination of Senescent Cells by Maciej Wnuk (825978)

“…In the present study, we have designed a nanoplatform composed of iron oxide nanoparticles functionalized with an antibody against a cell surface marker of senescent cells (CD26), and loaded with the senolytic drug HSP90 inhibitor 17-DMAG (MNP@CD26@17D). …”

Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma by Monica Mossenta (4276213)